Nahoko Kasahara-Ito

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus

S. Iida, Tomohisa Saito, D. Schwab, 2018, Drug Research.

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects

T. Ichihara, Y. Kumagai, H. Fukase, 2017, Drug Research.